OpenAlex
PricingAboutJobs
Log inGet started
Work

Drug Development, Trial Design, and Endpoints in Oncology: Adapting to Rapidly Changing Science

HTML

Year: 2017
Type: article
Source: Clinical Pharmacology & Therapeutics
DOI: 10.1002/cpt.623
Authors: GM Blumenthal, KB Goldberg, R Pazdur
Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research
Language: English

Topic: Statistical Methods in Clinical Trials
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Keywords: anticancer drug development, clinical trial design, clinical trial endpoints, targeted cancer therapy, cancer immunotherapy, breakthrough therapies, expansion cohort, breakthrough therapy designation, accelerated approval, regulatory science
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2575455970
FWCI: 1.811
Cites: 8
Cited by: 18
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security